Cargando…
Evaluating chronic disease management : recommendations for funders and users /
The report forms part of the DISMEVAL project, funded under the European Commission's 7th Framework Programme. It is targeted at policymakers, programme operators and researchers, explaining choices, options and trade-offs for the evaluation of disease management based on analyses undertaken wi...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Santa Monica, CA :
RAND Corporation,
2012.
|
| Colección: | Technical report (Rand Corporation) ;
TR-1213-EC. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | JSTOR_ocn894626407 | ||
| 003 | OCoLC | ||
| 005 | 20231005004200.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 140829s2012 enka obt 000 0 eng | ||
| 040 | |a NLM |b eng |e rda |e pn |c NLM |d RSM |d JSTOR |d OCLCF |d YDXCP |d TEF |d OCLCQ |d LOA |d LND |d ICG |d U3W |d OCLCQ |d ERL |d WYU |d NJT |d OCLCO |d OCLCA |d NLM |d OCLCO |d VHC |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 016 | 7 | |a 101640337 |2 DNLM | |
| 019 | |a 847596904 |a 867483646 |a 1182821504 |a 1303397177 | ||
| 020 | |a 9780833079558 | ||
| 020 | |a 0833079557 | ||
| 027 | |a RAND/TR-1213-EC | ||
| 029 | 0 | |a NLM |b 101640337 | |
| 029 | 1 | |a AU@ |b 000051481139 | |
| 029 | 1 | |a AU@ |b 000061194993 | |
| 029 | 1 | |a GBVCP |b 1008662674 | |
| 035 | |a (OCoLC)894626407 |z (OCoLC)847596904 |z (OCoLC)867483646 |z (OCoLC)1182821504 |z (OCoLC)1303397177 | ||
| 037 | |a 22573/ctt36t6wd |b JSTOR | ||
| 042 | |a pcc | ||
| 043 | |a e------ | ||
| 050 | 4 | |a RA399.5 |b .E9 2012 | |
| 060 | 0 | 0 | |a WT 500 |
| 082 | 0 | 4 | |a 362.1 |2 23 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Nolte, Ellen, |e author. | |
| 245 | 1 | 0 | |a Evaluating chronic disease management : |b recommendations for funders and users / |c Ellen Nolte [and 19 others] ; prepared for the European Commission on behalf of the DISMEVAL Consortium. |
| 264 | 1 | |a Santa Monica, CA : |b RAND Corporation, |c 2012. | |
| 300 | |a 1 online resource (1 PDF file (xv, 85 pages)) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Technical report ; |v TR-1213-EC | |
| 500 | |a Title from PDF title page. | ||
| 504 | |a Includes bibliographical references. | ||
| 520 | 3 | |a The report forms part of the DISMEVAL project, funded under the European Commission's 7th Framework Programme. It is targeted at policymakers, programme operators and researchers, explaining choices, options and trade-offs for the evaluation of disease management based on analyses undertaken within the project. Many of the issues discussed can be seen to apply to any evaluation of complex interventions in healthcare. However, there are specific concerns around evaluation design and metrics that are of relevance to the evaluation of disease management in particular and that are examined in the report. These include (i) the context for evaluating disease management, exploring the reasons for undertaking evaluation in the first place and explaining some of the underlying principles for doing so; (ii) the methods and metrics for evaluating disease management, focusing specifically on themes that have emerged as being pertinent to work carried out within the DISMEVAL project; (iii) practical considerations for disease management evaluation, based on experience of work undertaken in DISMEVAL; and (v) the broader challenges and lessons learned that may be relevant for policymakers, funders and practitioners interested in the use and usefulness of disease management evaluation more generally. This publication provides a major resource to guide the evaluation of disease management interventions in European settings and so contributes to strengthening the evidence-base required to inform the selection of efficient and effective interventions to address the growing burden of chronic disease in Europe. | |
| 588 | 0 | |a Version viewed Oct. 20, 2014. | |
| 505 | 0 | |a Introduction -- The context for evaluating chronic disease management -- Methods and metrics for evaluation: experiences from the DISMEVAL project -- Practical considerations for evaluation -- Challenges and lessons learned -- Going forward: Conclusions and further research -- Appendix A: Summary overview of six DISMEVAL work packages on disease management evaluation methods and metrics -- Appendix B: Evaluation measures for disease management (DM) interventions. | |
| 538 | |a Mode of access: internet via WWW. |5 CStmoR | ||
| 590 | |a JSTOR |b Books at JSTOR Open Access | ||
| 590 | |a JSTOR |b Books at JSTOR All Purchased | ||
| 610 | 2 | 2 | |a DISMEVAL Project |
| 650 | 0 | |a Disease management |z Europe. | |
| 650 | 0 | |a Disease management. | |
| 650 | 0 | |a Evidence-based medicine. | |
| 650 | 0 | |a Outcome assessment (Medical care) | |
| 650 | 1 | 2 | |a Chronic Disease |x economics |
| 650 | 1 | 2 | |a Chronic Disease |x therapy |
| 650 | 2 | |a Disease Management | |
| 650 | 2 | |a Evidence-Based Practice | |
| 650 | 2 | |a Outcome Assessment, Health Care | |
| 650 | 2 | |a Outcome and Process Assessment, Health Care | |
| 650 | 2 | 2 | |a Cost of Illness |
| 650 | 2 | 2 | |a Evidence-Based Medicine |
| 650 | 2 | 2 | |a Treatment Outcome |
| 650 | 6 | |a Gestion thérapeutique. | |
| 650 | 6 | |a Gestion thérapeutique |z Europe. | |
| 650 | 6 | |a Coût de la maladie. | |
| 650 | 6 | |a Médecine factuelle. | |
| 650 | 6 | |a Évaluation des résultats (Soins médicaux) | |
| 650 | 7 | |a Outcome assessment (Medical care) |2 fast | |
| 650 | 7 | |a Evidence-based medicine |2 fast | |
| 650 | 7 | |a Disease management |2 fast | |
| 651 | 7 | |a Europe |2 fast | |
| 655 | 2 | |a Evaluation Study | |
| 655 | 2 | |a Technical Report | |
| 710 | 2 | |a RAND Europe, |e issuing body. | |
| 710 | 2 | |a DISMEVAL Consortium, |e issuing body. | |
| 830 | 0 | |a Technical report (Rand Corporation) ; |v TR-1213-EC. | |
| 856 | 4 | 0 | |u https://jstor.uam.elogim.com/stable/10.7249/j.ctt3fh111 |z Texto completo |
| 938 | |a YBP Library Services |b YANK |n 11820893 | ||
| 994 | |a 92 |b IZTAP | ||